Mechanisms of Retinogenesis in Human Stem Cells
人类干细胞视网膜发生机制
基本信息
- 批准号:8146172
- 负责人:
- 金额:$ 35.64万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2010
- 资助国家:美国
- 起止时间:2010-09-30 至 2015-08-31
- 项目状态:已结题
- 来源:
- 关键词:AdoptedAffectAnimal ModelBiological ModelsCell Culture TechniquesCell Cycle RegulationCell ProliferationCell TherapyCellsCharacteristicsComplementCultured CellsDefectDevelopmentDiseaseDistalDysplasiaEventExhibitsEyeEye DevelopmentEye diseasesFaceFibroblast Growth FactorFoundationsFunctional disorderGenerationsGenesHealthHomeoboxHumanHuman DevelopmentImpairmentIndividualInheritedInvestigationKnowledgeLigandsMaintenanceMediatingMethodsMicrophthalmosMissionModelingMolecularMutationNeural RetinaOptic vesiclePathway interactionsPatientsPatternPluripotent Stem CellsPopulationProcessProductionProliferatingProteinsQuality of lifeRegulationRegulator GenesRepressionResearchRetinaRetinalRetinal DiseasesRoleSeminalSignal PathwaySignal TransductionSourceStagingStem cellsStructureStructure of retinal pigment epitheliumSurface EctodermSuspension CultureTestingTimeTissuesVertebratesVisionVisual system structurecell typecellular developmentclinically relevantdesignhuman embryonic stem cellhuman stem cellsimprovedin vitro Modelinduced pluripotent stem cellinhibitor/antagonistnovelpostnatalpublic health relevancerelating to nervous systemresearch studyresponseretinal progenitor cellretinogenesistheories
项目摘要
DESCRIPTION (provided by applicant): Inherited and acquired diseases of the neural retina (NR) and/or retinal pigment epithelium (RPE) are a significant issue in human health and quality of life. Stepwise retinal differentiation of human pluripotent stem cells (hPSCs) can provide a model system to study human retinal development and supply cells for the potential treatment of debilitating retinal diseases. We have shown that two types of hPSCs, human embryonic stem cells (hESCs) and human induced pluripotent stem cells (hiPSCs), can differentiate along the retinal lineage in a manner that closely parallels normal human retinogenesis. However, little is known about the factors and events that influence key steps in the differentiation of these cell types from hPSCs. Our long-term mission is to define molecular mechanisms of retinal cell fate determination from hPSCs and apply this knowledge to the study and treatment of human developmental and degenerative retinal disorders. An important step in vertebrate retinogenesis occurs during the optic vesicle (OV) stage, when cells make the seminal decision to develop either as a neural retinal progenitor cell (NRPC) or an RPE cell. VSX2 is the earliest known marker of NRPCs and is hypothesized to pattern the naove OV into the NR and RPE domains by repressing expression of the early RPE-associated gene MITF. Disruption of Vsx2 expression in animal models by various means causes severe defects of the eye and retina, and humans with mutations in this gene exhibit microphthalmia and malformed retinas. Despite the critical roles attributed to VSX2 during retinal development, there is scant information available on its mechanisms of action and regulation in humans. Our unique capability to culture human cell populations from the earliest stages of retinogenesis and to isolate OV- like structures provides a pertinent in vitro model system to study VSX2 function in human retinal cell development. The primary objectives of this proposal are to a) determine the purpose and necessity of VSX2 in the initial production of retinal cell types from hPSCs and b) identify endogenous hPSC signaling mechanisms that control VSX2 expression during differentiation. Experiments are designed to investigate the overall hypothesis that VSX2 expression in hPSC-derived retinal cultures leads to maintenance of a proliferating pool of NRPCs at the expense of RPE. To test this theory, we will pursue the following specific aims: 1. Determine the gene regulatory roles and mechanisms of VSX2 during the early production and proliferation of NRPCs in differentiating hPSCs. 2. Define the ligands and pathways that mediate the reciprocal effects of FGF and TGF2 signaling in the regulation of early VSX2 expression in differentiating hPSCs. 3. Determine the effects of a naturally occurring, human VSX2 mutation on the establishment and expansion of NRPC vs. RPE cell populations using patient-derived hiPSCs.
PUBLIC HEALTH RELEVANCE: The purpose of this proposal is to advance understanding of the development of the human retina. By using our stepwise method to coax stem cells to become a full range of retinal cell types in a culture dish, we can model how the building blocks of the human retina are produced, beginning at their most primitive stages. Such a model will have great value in the study of basic mechanisms of retinal development and the causes of inherited eye diseases, and will complement our efforts to develop cell-based therapies for degenerative retinal disorders.
描述(由申请人提供):神经视网膜(NR)和/或视网膜色素上皮(RPE)的遗传和获得的疾病是人类健康和生活质量的重要问题。人多能干细胞(HPSC)的逐步视网膜分化可以提供一个模型系统,以研究人类视网膜发育和供应细胞的潜在治疗视网膜疾病的潜在治疗。我们已经表明,两种类型的HPSC,人类胚胎干细胞(HESC)和人类诱导的多能干细胞(HIPSC)可以以与正常人视网膜生成相似的方式沿着视网膜谱系区分。但是,对影响这些细胞类型与HPSC分化的关键步骤的因素和事件知之甚少。我们的长期任务是从HPSC中定义视网膜细胞命运测定的分子机制,并将这些知识应用于人类发育和退化性视网膜疾病的研究和处理。脊椎动物视网膜生成的重要步骤是在视力囊泡(OV)阶段发生的,当细胞做出开创性决定为神经视网膜祖细胞(NRPC)或RPE细胞的决定。 VSX2是最早的NRPC标记物,假设通过抑制早期与RPE相关的基因MITF的表达来将Naove OV模拟到NR和RPE结构域中。动物模型中VSX2表达的破坏会导致眼睛和视网膜的严重缺陷,并且该基因中具有突变的人类表现出微观粒细胞和畸形的视网膜。尽管在视网膜发育过程中归因于VSX2的关键作用,但关于其人类的作用和调节机制的信息很少。我们从视网膜发生的最早阶段培养人类细胞群体的独特能力并分离出类似结构的结构为研究人类视网膜细胞发育中的VSX2功能提供了相关的体外模型系统。该提案的主要目标是a)确定VSX2在HPSC的视网膜细胞类型初始产生中的目的和必要性,b)识别内源性HPSC信号传导机制,以控制VSX2在分化过程中的表达。实验旨在研究总体假设,即HPSC衍生的视网膜培养物中的VSX2表达会导致维持增殖的NRPC库,而牺牲了RPE。为了检验该理论,我们将追求以下特定目的:1。确定NRPC在分化HPSC中的早期生产和NRPC增殖过程中VSX2的基因调节作用和机制。 2。定义介导FGF和TGF2信号在分化HPSC中早期VSX2表达的调节中介导的配体和途径。 3。确定使用患者衍生的HIPSC的NRPC与RPE细胞群体建立和扩展的自然发生的人类VSX2突变的影响。
公共卫生相关性:该提案的目的是提高对人视网膜发展的理解。通过使用我们的逐步方法哄骗干细胞成为培养皿中的整个视网膜细胞类型,我们可以建模如何产生人类视网膜的构件,从最原始的阶段开始。这种模型将在研究视网膜发育的基本机制和遗传性眼部疾病的原因方面具有很大的价值,并将补充我们为开发基于细胞的退化性视网膜疾病疗法的努力。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
David M Gamm其他文献
David M Gamm的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('David M Gamm', 18)}}的其他基金
Develop an engineered Cas effector for in vivo cell-targeted delivery in the eye to treat autosomal dominant BEST disease
开发工程化 Cas 效应器,用于眼内体内细胞靶向递送,以治疗常染色体显性 BEST 疾病
- 批准号:
10668167 - 财政年份:2023
- 资助金额:
$ 35.64万 - 项目类别:
Single Cell Profiling To Define Biomarkers Of Photoreceptor Dysfunction After Gene Editing Within PSC-Derived Organoids
在 PSC 衍生类器官中进行基因编辑后,通过单细胞分析来定义光感受器功能障碍的生物标志物
- 批准号:
10452673 - 财政年份:2018
- 资助金额:
$ 35.64万 - 项目类别:
Single Cell Profiling To Define Biomarkers Of Photoreceptor Dysfunction After Gene Editing Within PSC-Derived Organoids
在 PSC 衍生类器官中进行基因编辑后,通过单细胞分析来定义光感受器功能障碍的生物标志物
- 批准号:
10254334 - 财政年份:2018
- 资助金额:
$ 35.64万 - 项目类别:
Screening for Molecules that Promote Photoreceptor Synaptogenesis
筛选促进光感受器突触发生的分子
- 批准号:
9340197 - 财政年份:2016
- 资助金额:
$ 35.64万 - 项目类别:
Screening for Molecules that Promote Photoreceptor Synaptogenesis
筛选促进光感受器突触发生的分子
- 批准号:
9206652 - 财政年份:2016
- 资助金额:
$ 35.64万 - 项目类别:
相似国自然基金
肾—骨应答调控骨骼VDR/RXR对糖尿病肾病动物模型FGF23分泌的影响及中药的干预作用
- 批准号:82074395
- 批准年份:2020
- 资助金额:55 万元
- 项目类别:面上项目
基于细胞自噬调控的苦参碱对多囊肾小鼠动物模型肾囊肿形成的影响和机制研究
- 批准号:
- 批准年份:2019
- 资助金额:33 万元
- 项目类别:地区科学基金项目
NRSF表达水平对抑郁模型小鼠行为的影响及其分子机制研究
- 批准号:81801333
- 批准年份:2018
- 资助金额:21.0 万元
- 项目类别:青年科学基金项目
靶向诱导merlin/p53协同性亚细胞穿梭对听神经瘤在体生长的影响
- 批准号:81800898
- 批准年份:2018
- 资助金额:21.0 万元
- 项目类别:青年科学基金项目
伪狂犬病病毒激活三叉神经节细胞对其NF-кB和PI3K/Akt信号转导通路影响的分子机制研究
- 批准号:31860716
- 批准年份:2018
- 资助金额:39.0 万元
- 项目类别:地区科学基金项目
相似海外基金
Resolving sources of heterogeneity and comorbidity in alcohol use disorder
解决酒精使用障碍的异质性和合并症的来源
- 批准号:
10783325 - 财政年份:2023
- 资助金额:
$ 35.64万 - 项目类别:
Optimizing integration of veterinary clinical research findings with human health systems to improve strategies for early detection and intervention
优化兽医临床研究结果与人类健康系统的整合,以改进早期检测和干预策略
- 批准号:
10764456 - 财政年份:2023
- 资助金额:
$ 35.64万 - 项目类别:
Sodium channel mutations as a possible cause for primary dysautonomia
钠通道突变可能是原发性自主神经功能障碍的原因
- 批准号:
10586393 - 财政年份:2023
- 资助金额:
$ 35.64万 - 项目类别:
Heterogeneity and cellular hierarchy of lung cDC2
肺 cDC2 的异质性和细胞层次
- 批准号:
10665348 - 财政年份:2023
- 资助金额:
$ 35.64万 - 项目类别: